Novel Sensitizing Agents for Therapeutic Anti EGFR Antibodies

Produk Detail:
  • Author : Shi Hu
  • Publisher : Academic Press
  • Pages : 300 pages
  • ISBN : 9780128215845
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Novel Sensitizing Agents for Therapeutic Anti EGFR Antibodies

Download or Read online Novel Sensitizing Agents for Therapeutic Anti EGFR Antibodies full in PDF, ePub and kindle. this book written by Shi Hu and published by Academic Press which was released on 15 March 2021 with total page 300 pages. We cannot guarantee that Novel Sensitizing Agents for Therapeutic Anti EGFR Antibodies book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies presents an in-depth description of sensitizers to overcome resistance to anti-EGFR targeted antibody therapies in cancer, including novel engineered antibody drugs or other sensitizers. It gives an insight into the landscape of anti-EGFR based cancer treatment, the challenges of targeted therapy, and a glimpse into the future of antibody therapy. The book offers pertinent basic science information on strategies used for the rational design and discovery of novel sensitizing agents, and, in addition, translational studies involving pre-clinical and clinical design and execution with these novel agents. It covers basic science strategies that are being used in drug discovery and preclinical evaluation focused on EGFR blockage resistance, as well as clinical trial methodology including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new anticancer sensitizers for anti-EGFR drug resistance. This book is an indispensable resource for cancer researchers, medicinal chemists, and other biomedical scientists involved in the development of new therapeutic agents to overcome resistance to anti-EGFR treatments. Presents detailed description of history, chemistry, mechanism of action, structure-function relationships, pharmacology, side effects, dosing, and formulation of new sensitizers to anti-EGFR antibodies Provides molecular structures for all novel anticancer drugs and strategies to overcome resistance of anti-EGFR antibodies Encompasses up-to-date information on the cancer drug discovery process, including new research tools, tumor-targeting strategies, and fundamental concepts in the emerging areas of precision medicine

Novel Sensitizing Agents for Therapeutic Anti EGFR Antibodies

Novel Sensitizing Agents for Therapeutic Anti EGFR Antibodies
  • Author : Shi Hu
  • Publisher : Academic Press
  • Release : 15 March 2021
GET THIS BOOK Novel Sensitizing Agents for Therapeutic Anti EGFR Antibodies

Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies presents an in-depth description of sensitizers to overcome resistance to anti-EGFR targeted antibody therapies in cancer, including novel engineered antibody drugs or other sensitizers. It gives an insight into the landscape of anti-EGFR based cancer treatment, the challenges of targeted therapy, and a glimpse into the future of antibody therapy. The book offers pertinent basic science information on strategies used for the rational design and discovery of novel sensitizing agents, and, in addition,

Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy

Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy
  • Author : Dong-hua Yang
  • Publisher : Cancer Sensitizing Agents for
  • Release : 15 November 2018
GET THIS BOOK Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy

Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, Volume Four in the Cancer Sensitizing Agents for Chemotherapy Series focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and

Novel Therapies in Head and Neck Cancer Beyond the Horizon

Novel Therapies in Head and Neck Cancer  Beyond the Horizon
  • Author : Maie A. St. John,No hee Park
  • Publisher : Academic Press
  • Release : 29 June 2020
GET THIS BOOK Novel Therapies in Head and Neck Cancer Beyond the Horizon

Novel Therapies in Head and Neck Cancer: Beyond the Horizon, Volume Twelve, provides a high-level synthesis of the latest treatments and outcomes relating to head and neck cancer. Chemotherapy and immunotherapy for those cancer types are rapidly evolving, and an updated source based on the expertise of internationally renowned researchers is necessary. This book discusses the outcome of recent trials using chemotherapy, novel approaches for HPV+ SCCA, cases in which immunotherapy is more likely to be successful, and precision medicine

Novel Anticancer Agents

Novel Anticancer Agents
  • Author : Alex A. Adjei,John K. Buolamwini
  • Publisher : Academic Press
  • Release : 28 April 2011
GET THIS BOOK Novel Anticancer Agents

This book offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents. This book covers basic science strategies that are being used in drug discovery and preclinical evaluation focused on novel molecular targets, as well as clinical trial methodology including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new, relatively non-cytotoxic

Resistance to Immunotherapeutic Antibodies in Cancer

Resistance to Immunotherapeutic Antibodies in Cancer
  • Author : Benjamin Bonavida
  • Publisher : Springer Science & Business Media
  • Release : 04 August 2013
GET THIS BOOK Resistance to Immunotherapeutic Antibodies in Cancer

​​​​The traditional approaches to treat various cancers include chemotherapy, radiation and/or hormonal therapy. While these therapies continue to be effective in large part, they are not selective and highly toxic. There have been encouraging results in alternative therapeutic approach called antibody-mediated anti-cancer therapy, which is less toxic, more selective, and can also reverse drug/radiation resistance. Monoclonal antibodies or mAbs can be used to destroy malignant tumor cells and prevent tumor growth by blocking specific cell receptors. mAbs can

Sensitization of Cancer Cells for Chemo Immuno Radio therapy

Sensitization of Cancer Cells for Chemo Immuno Radio therapy
  • Author : Benjamin Bonavida
  • Publisher : Springer Science & Business Media
  • Release : 31 July 2008
GET THIS BOOK Sensitization of Cancer Cells for Chemo Immuno Radio therapy

This book reviews novel approaches developed to reverse tumor cell resistance to chemo/immuno/radio-therapy and the use of various sensitizing agents in combination with various cytotoxics. It also introduces several current approaches developed by established investigators that are aimed at overcoming resistance. This is the first volume to compile studies on tumor cell sensitization. It will prove useful for students, scientists, clinicians and pharmaceutical companies.

Abeloff s Clinical Oncology E Book

Abeloff s Clinical Oncology E Book
  • Author : John E. Niederhuber,James O. Armitage,James H Doroshow,Michael B. Kastan,Joel E. Tepper
  • Publisher : Elsevier Health Sciences
  • Release : 08 January 2019
GET THIS BOOK Abeloff s Clinical Oncology E Book

Easily accessible and clinically focused, Abeloff's Clinical Oncology, 6th Edition, covers recent advances in our understanding of the pathophysiology of cancer, cellular and molecular causes of cancer initiation and progression, new and emerging therapies, current trials, and much more. Masterfully authored by an international team of leading cancer experts, it offers clear, practical coverage of everything from basic science to multidisciplinary collaboration on diagnosis, staging, treatment and follow up. Includes new chapters on Cancer Metabolism and Clinical Trial Designs in

Radiosensitizers and Radiochemotherapy in the Treatment of Cancer

Radiosensitizers and Radiochemotherapy in the Treatment of Cancer
  • Author : Shirley Lehnert
  • Publisher : CRC Press
  • Release : 08 December 2014
GET THIS BOOK Radiosensitizers and Radiochemotherapy in the Treatment of Cancer

Radiosensitizers and Radiochemotherapy in the Treatment of Cancer catalogs and describes the mechanism of action for entities characterized as radiosensitizers. Developments in the biological and physical sciences have introduced new radiosensitizers and defined novel targets for radiosensitization. As a result, a book about radiosensitization must now address a huge range of topics, covering everything from molecular oxygen and high Z elements to monoclonal antibodies and complex phytochemicals. At the molecular level, the understanding of the molecular consequences of DNA damage

Clinical Radiation Oncology E Book

Clinical Radiation Oncology E Book
  • Author : Leonard L. Gunderson,Joel E. Tepper
  • Publisher : Elsevier Health Sciences
  • Release : 16 June 2015
GET THIS BOOK Clinical Radiation Oncology E Book

Perfect for radiation oncology physicians and residents needing a multidisciplinary, treatment-focused resource, this updated edition continues to provide the latest knowledge in this consistently growing field. Not only will you broaden your understanding of the basic biology of disease processes, you'll also access updated treatment algorithms, information on techniques, and state-of-the-art modalities. The consistent and concise format provides just the right amount of information, making Clinical Radiation Oncology a welcome resource for use by the entire radiation oncology team. Content

Brain Tumors E Book

Brain Tumors E Book
  • Author : Andrew H. Kaye,Edward R. Laws Jr
  • Publisher : Elsevier Health Sciences
  • Release : 06 December 2011
GET THIS BOOK Brain Tumors E Book

Meet the increasing need for effective brain tumor management with the highly anticipated revision of Brain Tumors by Drs. Andrew H. Kaye and Edward R. Laws. Over the past decade, enormous advances have been made in both the diagnosis and the surgical and radiotherapeutic management of brain tumors. This new edition guides you through the latest developments in the field, including hot topics like malignant gliomas, functional brain mapping, neurogenetics and the molecular biology of brain tumors, and biologic and

Gunderson Tepper s Clinical Radiation Oncology E Book

Gunderson   Tepper   s Clinical Radiation Oncology  E Book
  • Author : Joel E. Tepper
  • Publisher : Elsevier Health Sciences
  • Release : 06 December 2019
GET THIS BOOK Gunderson Tepper s Clinical Radiation Oncology E Book

A comprehensive, multidisciplinary resource for the entire radiation oncology team, Gunderson & Tepper’s Clinical Radiation Oncology, 5th Edition, thoroughly covers all aspects of this complex and dynamic field. Concise, templated chapters cover the basic biology of oncologic disease processes as well as updated treatment algorithms, the latest clinical guidelines, and state-of-the-art techniques and modalities. More than 1,000 images—detailed anatomy drawings, radiographic images, and more—provide outstanding visual support for every area of the text. Divides content into three distinct sections

Radiation Oncology E Book

Radiation Oncology E Book
  • Author : James D. Cox,Kie Kian Ang
  • Publisher : Elsevier Health Sciences
  • Release : 29 October 2009
GET THIS BOOK Radiation Oncology E Book

Radiation Oncology: Rationale, Technique, Results, by James D. Cox, MD and K. Kian Ang, MD, PhD, provides you with authoritative guidance on the latest methods for using radiotherapy to treat patients with cancer. Progressing from fundamental principles through specific treatment strategies for the cancers of each organ system, it also addresses the effects of radiation on normal structures and the avoidance of complications. This 9th edition covers the most recent indications and techniques in the field, including new developments in

Molecular Pathomechanisms and New Trends in Drug Research

Molecular Pathomechanisms and New Trends in Drug Research
  • Author : Gyorgy Keri,Istvan Toth
  • Publisher : CRC Press
  • Release : 14 November 2002
GET THIS BOOK Molecular Pathomechanisms and New Trends in Drug Research

Knowledge of the basic mechanisms of human disease is essential for any student or professional engaged in drug research and development. Functional gene analysis (genomics), protein analysis (proteomics), and other molecular biological techniques have made it possible to understand these cellular processes, opening up exciting opportunities for no

Antibody Mediated Drug Delivery Systems

Antibody Mediated Drug Delivery Systems
  • Author : Yashwant Pathak,Simon Benita
  • Publisher : John Wiley & Sons
  • Release : 17 April 2012
GET THIS BOOK Antibody Mediated Drug Delivery Systems

This book covers various aspects of antibody mediated drug deliverysystems – theoretical aspects, processing, viral andnon-viral vectors, and fields where these systems find and /or arebeing evaluated for applications as therapeutics and diagnostictreatment. Chapters discuss actual applications of techniques usedfor formulation and characterization. Applications areas includecancer, pulmonary, ocular diseases; brain drug delivery; andvaccine delivery. The contributing authors represent over 10different countries, covering recent developments happening aroundthe globe.

Oncology of Infancy and Childhood E Book

Oncology of Infancy and Childhood E Book
  • Author : Stuart H. Orkin,David E. Fisher,A. Thomas Look,Samuel Lux,David Ginsburg,David G. Nathan
  • Publisher : Elsevier Health Sciences
  • Release : 09 June 2009
GET THIS BOOK Oncology of Infancy and Childhood E Book

To address the growing complexities of childhood cancer, Nathan and Oski’s Hematology and Oncology of Infancy and Childhood has now been separated into two distinct volumes. With this volume devoted strictly to pediatric oncology, and another to pediatric hematology, you will be on the cutting edge of these two fields. This exciting new, full-color reference provides you with the most comprehensive, authoritative, up-to-date information for diagnosing and treating children with cancer. It brings together the pathophysiology of disease with